Is HWKN a Buy? What to Consider in 2026

Last updated July 2026

Short answer

The bull case for Hawkins (HWKN) rests on Water Treatment roll-up: Water Treatment is the fastest-growing segment, up roughly 28% year over year in the first quarter of fiscal 2026. Revenue (FY2026, TTM) is ~$1.08 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: The largest risk is valuation: the stock trades at a premium P/E well above the chemicals-industry and peer averages, so any growth disappointment could compress the multiple. Whether HWKN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Hawkins, Inc. (NASDAQ: HWKN) is a specialty chemicals company founded in 1938 and headquartered in Roseville, Minnesota. It operates through three segments: Water Treatment (chemicals, equipment, and services for potable water, municipal and industrial wastewater, pools, and agriculture), Industrial (chemicals and blends for food, pharmaceutical, energy, electronics, and plating customers), and Health and Nutrition (ingredient distribution and formulation for supplements, functional foods, and personal care). Water Treatment has become the growth engine, expanded aggressively through a string of regional acquisitions such as WaterSurplus. The investment picture is one of a steady industrial compounder. In fiscal 2026 the company crossed $1 billion in revenue for the first time, delivered record profitability, and extended a dividend streak that now spans more than four decades. The tradeoff for investors is valuation: after a strong multi-year run the stock trades at a meaningful premium to the broader chemicals sector, so returns increasingly depend on continued acquisition execution and margin discipline in the Water Treatment segment rather than on a cheap starting price.

What's the case for buying HWKN?

1. Water Treatment roll-up

Water Treatment is the fastest-growing segment, up roughly 28% year over year in the first quarter of fiscal 2026. Hawkins has been acquiring regional water treatment businesses (including WaterSurplus and several tuck-ins) to expand geographic reach and add recurring service revenue. This gives the company a repeatable growth playbook in an essential, non-cyclical end market.

2. Record profitability and margin mix

Fiscal 2026 produced record revenue, net income, and adjusted EBITDA, with gross profit rising to roughly $245 million. The shift toward higher-margin water treatment services and blended products has supported margins even as the lower-margin Industrial segment faces commodity pass-through dynamics.

3. Long dividend and cash-return record

Hawkins has paid a dividend for more than 40 consecutive years and raised it again in fiscal 2026. Consistent free cash flow funds both the dividend and bolt-on acquisitions, giving the company an internally-funded growth model that appeals to income-and-quality oriented holders.

4. Essential, non-discretionary end markets

Municipal and industrial water treatment demand is tied to regulation, public health, and infrastructure rather than the economic cycle. That gives Hawkins relatively stable, defensive revenue compared with more cyclical chemical producers, supporting steadier through-cycle results.

What are the risks to HWKN?

The largest risk is valuation: the stock trades at a premium P/E well above the chemicals-industry and peer averages, so any growth disappointment could compress the multiple. The acquisition-led strategy carries integration and overpayment risk, and the fiscal 2026 borrowing to fund deals added leverage to fund future purchases. The Industrial segment is exposed to raw-material cost swings and pass-through timing that can pressure margins. Health and Nutrition is smaller and more volatile in demand. Finally, the company is relatively small and concentrated in North America, so a single large deal or region can meaningfully affect results.

How is HWKN valued? (as of July 2026)

Price

$143.84

Market cap

$3.01B

P/E (TTM)

36.79

Forward P/E

26.66

Price / book

6.80

Beta

0.78

52-week range

$117.98 to $186.15

Snapshot for HWKN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (FY2026, TTM): ~$1.08 billion
Net income (FY2026): ~$81.5 million
Adjusted EBITDA (FY2026): ~$179 million
Market cap: ~$3.1 billion
P/E (trailing): ~35-39x
EV/EBITDA: ~20x

Fiscal 2026 (ended in spring 2026) was a record year, with revenue up about 11% and Hawkins crossing $1 billion in sales for the first time. At a trailing P/E in the mid-to-high 30s and roughly 20x EV/EBITDA, the shares trade at a premium to the US chemicals sector average and to close peers. The premium reflects the market pricing in continued acquisition-led water treatment growth.

How do you decide if HWKN is a buy?

Rather than asking whether HWKN is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold HWKN indirectly through an index or sector ETF before adding more.

For the full picture, see the HWKN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HWKN against your real portfolio and see your actual exposure before deciding.

The bottom line on HWKN

The bottom line: Hawkins's story right now is Water Treatment roll-up, with revenue (fy2026, ttm) at ~$1.08 billion. If you believe that narrative continues, the call is about sizing HWKN sensibly and checking overlap with what you own; if you doubt it (the risk: the largest risk is valuation: the stock trades at a premium P/E well above the chemicals-industry and peer averages, so any growth disappointment could compress the multiple.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around HWKN with Walnut

Use Hawkins as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is HWKN a good stock to buy right now?

The case for Hawkins right now is Water Treatment roll-up, with revenue (fy2026, ttm) at ~$1.08 billion. If you believe that thesis holds, HWKN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is the largest risk is valuation: the stock trades at a premium P/E well above the chemicals-industry and peer averages, so any growth disappointment could compress the multiple. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Hawkins do?

Hawkins, Inc.

What are the main risks of HWKN?

What does Hawkins, Inc. (HWKN) do?

Hawkins is a US specialty chemicals company that formulates, distributes, and blends chemicals across three segments: Water Treatment, Industrial, and Health and Nutrition. Water Treatment, serving municipal and industrial water customers, is its largest growth driver.

Is HWKN a water stock?

Partly. Water Treatment is Hawkins's biggest and fastest-growing segment, so it is often grouped with water-infrastructure names, but it also runs sizable Industrial and Health and Nutrition businesses, making it a diversified specialty chemicals company rather than a pure-play water stock.

How fast is Hawkins growing?

In fiscal 2026 revenue rose about 11% to roughly $1.08 billion, its first year above $1 billion. Growth has been driven by the Water Treatment segment, which expanded roughly 28% year over year in the first quarter of fiscal 2026, largely through acquisitions.

Does HWKN pay a dividend?

Yes. Hawkins has paid a dividend for more than 40 consecutive years and raised it again in fiscal 2026 to about $0.75 per share for the year. The yield is modest, reflecting the stock's premium valuation, and the company emphasizes reinvestment and acquisitions.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell HWKN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.